SCHEMBL559639

SCHEMBL559639

C1=CC=NOC=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2797109 1.00
SCHEMBL4446554 1.00
SCHEMBL2797113 1.00
SCHEMBL4446556 1.00
SCHEMBL6182164 1.00
Hydrochloric Acid SCHEMBL8123314 0.97
Bromide SCHEMBL11408199 0.97
Hydrochloric Acid SCHEMBL30218243 0.97
Phosphine SCHEMBL27570808 0.97
SCHEMBL28182951 0.97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260083751-A1 ALLOSTERIC MODULATORS OF ANDROGEN RECEPTOR COACTIVATOR RECRUITMENT FOR CRPC THERAPY UNIVERSITY OF PITTSBURGH – OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2026-03-26 US claimed
US-20250304558-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF EPILEPSY OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2025-10-02 US claimed
EP-4611743-A1 TRIAZINES USEFUL AS INHIBITORS OF NOD-LIKE RECEPTOR PROTEIN 3 Merck Sharp & Dohme LLC (US) 2025-09-10 EP claimed
US-12391674-B2 Heterocyclic compounds for the treatment of epilepsy OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2025-08-19 US claimed
CN-118652223-A Oxazepine compound and preparation method thereof 抚州三和医药化工有限公司 2024-09-17 CN claimed
WO-2024131776-A1 BUFALIN DERIVATIVE AND PREPARATION METHOD THEREFOR, COMPOSITION, PREPARATION, AND APPLICATION 上海邈基生物科技有限公司 2024-06-27 WO claimed
WO-2024097598-A1 TRIAZINES USEFUL AS INHIBITORS OF NOD-LIKE RECEPTOR PROTEIN 3 MERCK SHARP & DOHME LLC (US) 2024-05-10 WO claimed
WO-2024050433-A1 ALLOSTERIC MODULATORS OF ANDROGEN RECEPTOR COACTIVATOR RECRUITMENT FOR CRPC THERAPY UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2024-03-07 WO claimed
CN-117567515-A Triple negative breast cancer targeting compound and preparation method and application thereof 天津工业大学 2024-02-20 CN claimed
CN-112457287-B Preparation method of E-olopatadine 重庆西南制药二厂有限责任公司 2024-02-06 CN claimed
CN-106414432-A Optionally substituted quinoline compounds 卫材R&D管理有限公司 2017-02-15 CN claimed
US-9186461-B2 Viscous formulations and their use in needle-free injection ZOGENIX, INC. (US) 2015-11-17 US claimed
US-8876758-B2 Viscous formulations and their use in needle-free injection ZOGENIX, INC. (US) 2014-11-04 US claimed
US-20120296270-A1 VISCOUS FORMULATIONS AND THEIR USE IN NEEDLE-FREE INJECTION ZOGENIX, INC. 2012-11-22 US claimed
CN-1980931-A Compounds with atypical antipsychotic activity SIGMA TAU IND FARMACEUTI (IT) 2007-06-13 CN claimed
US-6774229-B2 PROCESS FOR THE PREPARATION OF AROMATIC OR NON-AROMATIC HETEROCYCLES HAVING FROM 4 TO 10, PREFERABLY FROM 5 TO 7, RING MEMBERS; USED AS FUNGICIDES, ANTIMICROBIALS AND BACTERICIDES MORPHOCHEM AG (DE) 2004-08-10 US claimed
EP-1233944-B1 COUPLING CONDENSATION SYNTHESIS OF HETEROCYCLES MORPHOCHEM AG (DE) 2004-03-31 EP claimed
EP-1337526-A1 SUBSTITUTED IMIDAZOLES USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES Ortho-McNeil Pharmaceutical, Inc. (US) 2003-08-27 EP claimed
US-20030100751-A1 Coupling condensation synthesis of heterocycles MORPHOCHEM AG (DE) 2003-05-29 US claimed
WO-2002032894-A1 SUBSTITUTED IMIDAZOLES USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2002-04-25 WO claimed